These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Elmarakby AA; Sullivan JC Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759 [TBL] [Abstract][Full Text] [Related]
5. Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets. Mima A J Diabetes Res; 2013; 2013():248563. PubMed ID: 23862164 [TBL] [Abstract][Full Text] [Related]
6. Extracts and Marine Algae Polysaccharides in Therapy and Prevention of Inflammatory Diseases of the Intestine. Besednova NN; Zaporozhets TS; Kuznetsova TA; Makarenkova ID; Kryzhanovsky SP; Fedyanina LN; Ermakova SP Mar Drugs; 2020 May; 18(6):. PubMed ID: 32486405 [TBL] [Abstract][Full Text] [Related]
7. Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice. Feng Y; Weng H; Ling L; Zeng T; Zhang Y; Chen D; Li H Int J Biol Macromol; 2019 Jul; 132():1001-1011. PubMed ID: 30946910 [TBL] [Abstract][Full Text] [Related]
8. Anti-Inflammatory Mechanisms of Fucoidans to Treat Inflammatory Diseases: A Review. Sanjeewa KKA; Herath KHINM; Yang HW; Choi CS; Jeon YJ Mar Drugs; 2021 Nov; 19(12):. PubMed ID: 34940677 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of fucoidan against kidney diseases: Pharmacological insights and future perspectives. Zahan MS; Hasan A; Rahman MH; Meem KN; Moni A; Hannan MA; Uddin MJ Int J Biol Macromol; 2022 Jun; 209(Pt B):2119-2129. PubMed ID: 35500767 [TBL] [Abstract][Full Text] [Related]
10. An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy. Li KX; Ji MJ; Sun HJ Gene; 2021 May; 780():145532. PubMed ID: 33631244 [TBL] [Abstract][Full Text] [Related]
11. Role of Toll-like receptors in diabetic nephropathy. Mudaliar H; Pollock C; Panchapakesan U Clin Sci (Lond); 2014 May; 126(10):685-94. PubMed ID: 24490813 [TBL] [Abstract][Full Text] [Related]
12. A novel chalcone derivative attenuates the diabetes-induced renal injury via inhibition of high glucose-mediated inflammatory response and macrophage infiltration. Fang Q; Zhao L; Wang Y; Zhang Y; Li Z; Pan Y; Kanchana K; Wang J; Tong C; Li D; Liang G Toxicol Appl Pharmacol; 2015 Jan; 282(2):129-38. PubMed ID: 25447405 [TBL] [Abstract][Full Text] [Related]
14. New therapeutic agents in diabetic nephropathy. Kim Y; Park CW Korean J Intern Med; 2017 Jan; 32(1):11-25. PubMed ID: 28049280 [TBL] [Abstract][Full Text] [Related]
15. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses. Chen J; Hou XF; Wang G; Zhong QX; Liu Y; Qiu HH; Yang N; Gu JF; Wang CF; Zhang L; Song J; Huang LQ; Jia XB; Zhang MH; Feng L J Ethnopharmacol; 2016 Dec; 193():433-444. PubMed ID: 27664441 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update. Bhattacharjee N; Barma S; Konwar N; Dewanjee S; Manna P Eur J Pharmacol; 2016 Nov; 791():8-24. PubMed ID: 27568833 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice. Chen H; Yang X; Lu K; Lu C; Zhao Y; Zheng S; Li J; Huang Z; Huang Y; Zhang Y; Liang G Toxicol Lett; 2017 Aug; 278():48-58. PubMed ID: 28700904 [TBL] [Abstract][Full Text] [Related]
19. An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy. Zhu X; Xu X; Du C; Su Y; Yin L; Tan X; Liu H; Wang Y; Xu L; Xu X Biomed Pharmacother; 2022 Sep; 153():113438. PubMed ID: 36076553 [TBL] [Abstract][Full Text] [Related]